We conducted a nested case-control study to 583-585 (1997) 
Introduction
Considerable data indicate that sex hormones play a major role in the etiology of breast cancer. Breast tumors frequently are hormonally dependent and a woman's reproductive history affects her risk (1 Women were eligible for the current study if they had at least 4 ml of blood remaining in the bank and if, at the time of blood collection, they had no history of cancer other than nonmelanoma skin cancer, were not diagnosed with benign breast disease within the previous 2 years, were postmenopausal, and did not report taking replacement estrogens. Of the 3375 women who met these criteria, 72 were diagnosed with histologically confirmed breast cancer. For each of these cases, two controls were selected from among the eligible women, using incidence density sampling. Controls were alive and free of cancer (except nonmelanoma skin cancer) at the age of the case's diagnosis and were matched to the case on exact age and on date (± 1 year) and time (± 2 hr) of blood draw. (8) . Percent unbound and albumin-bound estradiol were measured using centrifugal ultrafiltration (9) , and sex hormone-binding globulin (SHBG)-bound estradiol was calculated.
The relationship between serum hormones and breast cancer risk for the matched sets were evaluated using conditional logistic regression (10) 
Discussion
Results of this prospective study provide strong support for a relationship between serum sex hormone levels and the subsequent development of breast cancer in postmenopausal women. Women in the upper three quartiles of estradiol were at an elevated risk of breast cancer. The relationship was more consistent for non-SHBG-bound estradiol, the fraction that is biologically available, than for total estradiol. Serum levels of the androgens, testosterone, androstenedione, and DHEAS, all were positively associated with breast cancer risk. The association was strongest for testosterone, but we could not discern whether that association was a cause or an effect of the malignancy. Additional studies are needed to determine how serum hormone levels modify breast cancer risk in postmenopausal women.
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